Karuna Therapeutics to Present at Upcoming Investor Conferences

Karuna Therapeutics, Inc. KRTX, an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that senior management will participate in the following upcoming virtual investor conferences:

William Blair's Biotech Focus Conference

Date: Thursday, August 6, 2020

Time: 10:00 a.m. EDT

Wedbush PacGrow Healthcare Virtual Conference

Date: Tuesday, August 11, 2020

Time: 10:55 a.m. EDT

Canaccord Genuity 40th Annual Growth Conference

Date: Wednesday, August 12, 2020

Time: 4:00 p.m. EDT

JMP Securities CNS Forum

Date: Wednesday, August 19, 2020

Time: 11:30 a.m. EDT

A live webcast of the Wedbush presentation will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcast will also be archived for up to 90 days on Karuna's website following the conference.

About Karuna

Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today's neuropsychiatric and pain management patients deserve better, Karuna's mission is to harness the untapped potential of the brain's complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!